Aging · 2023 · 10 citations · 17 references
MedicineBioinformaticsOncologyAgingMolecular OncologyTumor ImmunologyCancer BiomarkersCancer ClusteringCancer GenomicsCancer TranscriptomicsImmuno-oncology BiomarkersMulti-omics Biomarker DiscoveryCancer BioinformaticsCancer Prognostic ModelingIntegrated Multi-omics AnalysisNon-negative Matrix FactorizationPrognostic Biomarker DiscoveryPrognostic Biomarker ModelingPrognostic Expression SignaturesPrognostic Prediction
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant tumor with high incidence and mortality rates. Aging-related genes are closely related to the occurrence and development of cancer. Therefore, it is of great significance to evaluate the prognosis of HCC patients by constructing a model based on aging-related genes. METHOD: Non-negative matrix factorization (NMF) clustering analysis was used to cluster the samples. The correlation between the risk score and immune cells, immune checkpoints, and Mismatch Repair (MMR) was evaluated through Spearman correlation test. Real Time Quantitative PCR (RT-qPCR) and immunohistochemistry were used to validate the expression levels of key genes in tissue and cells for the constructed model. RESULT: By performing NMF clustering, we were able to effectively group the liver cancer samples into two distinct clusters. Considering the potential correlation between aging-related genes and the prognosis of liver cancer patients, we used aging-related genes to construct a prognostic model. Spearman correlation analysis showed that the model risk score was closely related to MMR and immune checkpoint expression. Drug sensitivity analysis also provided guidance for the clinical use of chemotherapy drugs. RT-qPCR showed that TFDP1, NDRG1, and FXR1 were expressed at higher levels in different liver cancer cell lines compared to normal liver cells. CONCLUSION: In summary, we have developed an aging-related model to predict the prognosis of hepatocellular carcinoma and guide clinical drug treatment for different patients.
17
Tumour evolution inferred by single-cell sequencing
Nicholas E. Navin, Jude Kendall, Jennifer Troge et al. · Nature · 2011 · 2.7K citations · Full text
Valérie Bonadona · JAMA · 2011 · 1.1K citations · Full text
Life Sciences, Genetics, Oncology +17
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma
Jun Cheng, Haiyang Xie, Xiao Xu et al. · Cancer Letters · 2011 · 167 citations
Medicine, Cancer Biology, Oncology +14